FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:357-362 August 10, 1989 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

There is evidence that aspirin in low doses favorably influences the course of pregnancy-induced hypertension, but the mechanism, although assumed to involve suppression of the production of thromboxane by platelets, has not been established. We performed a randomized study of the effect of the long-term daily administration of 60 mg of aspirin (n = 17) or placebo (n = 16) on platelet thromboxane A2 and vascular prostacyclin in women at risk for pregnancy-induced hypertension. Low doses of aspirin were associated with a longer pregnancy and increased weight of newborns. Serum levels of thromboxane B2, a stable product of thromboxane A2, were almost completely (greater than 90 percent) inhibited by low doses of aspirin. The urinary excretion of immunoreactive thromboxane B2 was significantly reduced without changes in the level of 6-keto-prostaglandin F1 alpha, a product of prostacyclin. Mass spectrometric analysis showed that aspirin reduced the excretion of the 2,3-dinor-thromboxane B2 metabolite--mainly of platelet origin--by 81 percent and of thromboxane B2, probably chiefly of renal origin, by 59 percent. The urinary excretion of 6-keto-prostaglandin F1 alpha and of its metabolite 2,3-dinor-6-keto-prostaglandin F1 alpha was not affected. Low doses of aspirin only partially (63 percent) reduced neonatal serum thromboxane B2. No hemorrhagic complications were observed in the newborns. Thus, in women at risk for pregnancy-induced hypertension, low doses of aspirin selectively suppressed maternal platelet thromboxane B2 while sparing vascular prostacyclin, but only partially suppressed neonatal platelet thromboxane B2, allowing hemostatic competence in the fetus and newborn.

Source Information

Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

This article has been cited by other articles:

• Dechend, R., Homuth, V., Wallukat, G., Muller, D. N., Krause, M., Dudenhausen, J., Haller, H., Luft, F. C. (2006). Agonistic Antibodies Directed at the Angiotensin II, AT1 Receptor in Preeclampsia. Reproductive Sciences 13: 79-86 [Abstract]  
• Carbillon, L., Uzan, S., Brenner, B. (2005). Early treatment with low-dose aspirin is effective for the prevention of preeclampsia and related complications in high-risk patients selected by the analysis of their historic risk factors. Blood 105: 902-903 [Full Text]  
• Leonhardt, A., Bernert, S., Watzer, B., Schmitz-Ziegler, G., Seyberth, H. W. (2003). Low-Dose Aspirin in Pregnancy: Maternal and Neonatal Aspirin Concentrations and Neonatal Prostanoid Formation. Pediatrics 111: e77-81 [Abstract] [Full Text]  
• Alano, M. A., Ngougmna, E., Ostrea Jr, E. M., Konduri, G. G. (2001). Analysis of Nonsteroidal Antiinflammatory Drugs in Meconium and Its Relation to Persistent Pulmonary Hypertension of the Newborn. Pediatrics 107: 519-523 [Abstract] [Full Text]  
• Benigni, A., Remuzzi, G., van der Weiden, R. M. F., Helmerhorst, F. M., Mills, J. L., Levine, R. J., Morrow, J. D. (2000). Prostacyclin and Thromboxane and the Development of Preeclampsia. JAMA 283: 1568-1569 [Full Text]  
• Norwitz, E. R., Repke, J. T. (2000). Preeclampsia Prevention and Management. Reproductive Sciences 7: 21-36 [Abstract]  
• Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., Depp, R., The National Institute of Child Health and Human D, (1993). Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. NEJM 329: 1213-1218 [Abstract] [Full Text]  
• Kuban, K. C.K., Leviton, A., Pagano, M., Fenton, T., Strassfeld, R., Wolff, M. (1992). Maternal Toxemia Is Associated With Reduced Incidence of Germinal Matrix Hemorrhage in Premature Babies. J Child Neurol 7: 70-76 [Abstract]  
• Eskenazi, B., Fenster, L., Sidney, S. (1991). A Multivariate Analysis of Risk Factors for Preeclampsia. JAMA 266: 237-241 [Abstract]  
• Imperiale, T. F., Petrulis, A. S. (1991). A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease. JAMA 266: 260-264 [Abstract]  
• (1989). ASPIRIN REDUCES RISK OF TOXEMIA. JWatch General 1989: 3-3 [Full Text]